KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding
Others
Ratios

AbCellera Biologics (ABCL) EPS (Weighted Average and Diluted) (2020 - 2023)

Historic EPS (Weighted Average and Diluted) for AbCellera Biologics (ABCL) over the last 4 years, with Q4 2023 value amounting to -$0.17.

  • AbCellera Biologics' EPS (Weighted Average and Diluted) fell 7000.0% to -$0.17 in Q4 2023 from the same period last year, while for Dec 2023 it was -$0.52, marking a year-over-year decrease of 20400.0%. This contributed to the annual value of -$0.55 for FY2024, which is 784.31% down from last year.
  • AbCellera Biologics' EPS (Weighted Average and Diluted) amounted to -$0.17 in Q4 2023, which was down 7000.0% from -$0.1 recorded in Q3 2023.
  • AbCellera Biologics' 5-year EPS (Weighted Average and Diluted) high stood at $0.54 for Q1 2022, and its period low was -$0.17 during Q4 2023.
  • For the 4-year period, AbCellera Biologics' EPS (Weighted Average and Diluted) averaged around $0.06, with its median value being -$0.02 (2020).
  • As far as peak fluctuations go, AbCellera Biologics' EPS (Weighted Average and Diluted) soared by 380000.0% in 2021, and later plummeted by 42833.87% in 2023.
  • Over the past 4 years, AbCellera Biologics' EPS (Weighted Average and Diluted) (Quarter) stood at $0.44 in 2020, then plummeted by 56.82% to $0.19 in 2021, then crashed by 152.63% to -$0.1 in 2022, then plummeted by 70.0% to -$0.17 in 2023.
  • Its last three reported values are -$0.17 in Q4 2023, -$0.1 for Q3 2023, and -$0.11 during Q2 2023.